Information for MedStar Providers

In the MedConnect Message Center, please refer your patients to the Tobacco Education and Lung Health Study pool.

The TEAL study team will then contact your patient to present the study details and enroll those who are interested.  

Improve the benefit of lung cancer screening when your patients are encouraged to engage in tobacco treatment

Easily refer your patients to the TEAL study at the time you are ordering the LDCT scan

The TEAL study provides tobacco treatment & nicotine replacement/medication options to your patients who are referred for lung cancer screening

At the time you order lung cancer screening for your patient, please do not also refer the patient to the Tobacco Quitline.  The quitline is the control arm of the TEAL study and patients cannot be referred more than once in a 30 day period. 

Encourage your lung cancer screening patients who smoke to consider enrolling in TEAL when they are approached for study participation.

When your patients enroll in the trial, you will receive a MedConnect message with 3 days to let us know if you have any concerns about your patient enrolling in the trial.  

For participants who are randomly assigned to the Quitline study arm, we will send you a request to please sign the e-referral to the tobacco quitline 

Review MedConnect messages with updates on your patients’ progress in TEAL and in reaching their smoking goals. 

Follow-up with patients to continue supporting their efforts to quit or remain quit after the final study assessment occurs, six-months following enrollment

Improving the evidence-base of tobacco treatment for patients undergoing lung cancer screening

Addressing barriers to outreach and study engagement

Maximizing generalizability to other health systems

Evaluating effectiveness and economic outcomes of two cessation interventions for future implementation